ClinicalTrials.Veeva

Menu

Preemptive Analgesic Effects of Popliteal Sciatic Nerve Block in Patients With Bilateral Hallux Valgus Surgery

A

Asan Medical Center

Status

Unknown

Conditions

Pain, Postoperative
Acute Pain
Preemptive Peripheral Nerve Block

Treatments

Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03414593
2017-0856

Details and patient eligibility

About

The purpose of this study was to investigate the preemptive effect of ultrasound guided popliteal scistic nerve block on postoperative acute pain in patients with bilateral hallux valgus.

After induction of general anesthesia, the leg to be operated first is decided randomly. After the operation of one leg is completed, PSNB is performed on both legs with 0.2% Ropivacaine and surgery is started on the remaining legs.

When the surgery is over, check to see which foot pain begins first, how strong the pain is, and whether there are any side effects.

Enrollment

20 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. adults between the ages of 20 and 80
  2. bilateral hallux valgus surgery on the same day
  3. ASA class 1 or 2
  4. Patients who have voluntarily agreed in writing to participate in the trial

Exclusion criteria

  1. Patient with side effects on local anesthetics or steroids
  2. Patient who are taboo of peripheral nerve block such as blood clotting disorder, infection, etc.
  3. Patients with uncontrolled medical or psychiatric problem
  4. Patient does not agree to participate in the study
  5. Patients who are pregnant or lactating

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 2 patient groups

preoperative blocked leg: group preB
Experimental group
Description:
ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml Before surgical incision
Treatment:
Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine
postoperative blocked leg: group postB
Active Comparator group
Description:
ultrasound guided popliteal sciatic nerve block with 0.2% ropivacaine 20ml After surgical incision
Treatment:
Drug: Ultrasound guided popliteal sciatic nerve block with 0.2% ropivcaine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems